Actavia Life Sciences, Inc.
OTC: RASP0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Keeren Shah
- Employees
- 1
- Headquarters
- New York City, United States
- IPO year
- 2015
- Market cap
- $385.9K
- Website
- https://www.rasna.com
Loading RASP…
Loading profile data…Frequently asked questions about RASP
What does Actavia Life Sciences, Inc. (RASP) do?
Actavia Life Sciences, Inc. operates as a biotechnology enterprise specializing in the development of therapeutic solutions aimed at treating various forms of leukemia and lymphoma. Additionally, the company is engaged in formulating small molecule drug candidates, with a particular emphasis on addressing acute myeloid leukemia. Established in 2...
Where does RASP trade?
Actavia Life Sciences, Inc. (RASP) trades on the Other OTC.
What sector is RASP in?
Actavia Life Sciences, Inc. (RASP) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Actavia Life Sciences, Inc.?
Keeren Shah is the chief executive officer of Actavia Life Sciences, Inc. (RASP).
Where is Actavia Life Sciences, Inc. headquartered?
Actavia Life Sciences, Inc. is headquartered in United States.
Does RASP pay a dividend?
Actavia Life Sciences, Inc. (RASP) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RASP go public?
Actavia Life Sciences, Inc. (RASP) completed its initial public offering in 2015.